1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SPPL2C CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA CCP110 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA TGFBR1 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA KIAA1614 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA DOK6 CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA IL3RA CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA ZNF618 CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA SRRM3 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA PHF10 CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA ZNF704 CTRPv2 pan-cancer AAC 0.19 5e-07
Download CSV